F817-0533 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide

F817-0533 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide
F817-0533 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F817-0533
N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F817-0533

Molecular Formula

C23H28FN3O4S2 (C23 H28 FN3 O4 S2)

Compound Name

N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-1-{[4-(piperidine-1-carbonyl)thiophen-2-yl]sulfonyl}piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1S(c1cc(C(N2CCCCC2)=O)cs1)(=O)=O)NCc(cc1)ccc1F

InChI

InChI=1S/C23H28FN3O4S2/c24-20-6-4-17(5-7-20)15-25-22(28)18-8-12-27(13-9-18)33(30,31)21-14-19(16-32-21)23(29)26-10-2-1-3-11-26/h4-7,14,16,18H,1-3,8-13,15H2,(H,25,28)

InChI Key

GWNUJZCPGRFWLH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27194746

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.62

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.320

Distribution Coefficient, logD

2.320

Water Solubility, LogSw

-2.82

Polar Surface Area

74.029

Acid Dissociation Constant (pKa)

12.14

Base Dissociation Constant (pKb)

-2.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.80

F817-0533 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F817-0533 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F817-0533?
Check Price and Availability of F817-0533, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F817-0533 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F817-0533
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F817-0533
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F817-0533 available by request